Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease

被引:104
作者
Mössner, R
Henneberg, A
Schmitt, A
Syagailo, YV
Grässle, M
Hennig, T
Simantov, R
Gerlach, M
Riederer, P
Lesch, KP
机构
[1] Univ Wurzburg, Dept Psychiat, D-8700 Wurzburg, Germany
[2] Hosp Parkinsons Dis, Bad Nauheim, Germany
[3] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel
关键词
depression; serotonin transporter; promoter; polymorphism; monoamine oxidase A; Parkinson's disease;
D O I
10.1038/sj.mp.4000849
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Idiopathic Parkinson's disease (PD) is a common neurodegenerative disorder with prominent motor symptoms. However, depression is common in PD, affecting about 40% of PD patients. Since there is extensive evidence of degeneration of serotonin (5HT) neurons and loss of the 5HT transporter (5HTT) in PD, we assessed whether a functional polymorphism in the promoter of the 5HTT gene (5HTT gene-linked polymorphic region, 5HTTLPR), which determines high or low 5HT uptake, is associated with depressive symptomatology in PD patients. We found that patients with the short allele of the 5HTTLPR had significantly higher scores on the Hamilton Depression Scale. A functional promoter polymorphism of the monoamine oxidase A (MAOA) gene showed no association. Thus, the 5HTTLPR but not the MAOA gene promoter-associated polymorphism may be a risk factor for depression in PD patients, while neither polymorphism increases the risk for development of Parkinson's disease itself.
引用
收藏
页码:350 / 352
页数:3
相关论文
共 23 条
  • [1] HIGH AND LOW AFFINITY [H-3]IMIPRAMINE BINDING-SITES IN CONTROL AND PARKINSONIAN BRAINS
    CASH, R
    RAISMAN, R
    PLOSKA, A
    AGID, Y
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 117 (01) : 71 - 80
  • [2] CUMMINGS JL, 1992, AM J PSYCHIAT, V149, P443
  • [3] AMINERGIC SYSTEMS IN ALZHEIMERS-DISEASE AND PARKINSONS-DISEASE
    DAMATO, RJ
    ZWEIG, RM
    WHITEHOUSE, PJ
    WENK, GL
    SINGER, HS
    MAYEUX, R
    PRICE, DL
    SNYDER, SH
    [J]. ANNALS OF NEUROLOGY, 1987, 22 (02) : 229 - 236
  • [4] Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder
    Deckert, J
    Catalano, M
    Syagailo, YV
    Bosi, M
    Okladnova, O
    Di Bella, D
    Nöthen, MM
    Maffei, P
    Franke, P
    Fritze, J
    Maier, W
    Propping, P
    Beckmann, H
    Bellodi, L
    Lesch, KP
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (04) : 621 - 624
  • [5] Fahn S., RECENT DEV PARKINSON, V2, P153, DOI DOI 10.1002/ANA.410220556
  • [6] NEUROPATHOLOGY OF IMMUNOHISTOCHEMICALLY IDENTIFIED BRAIN-STEM NEURONS IN PARKINSONS-DISEASE
    HALLIDAY, GM
    LI, YW
    BLUMBERGS, PC
    JOH, TH
    COTTON, RGH
    HOWE, PRC
    BLESSING, WW
    GEFFEN, LB
    [J]. ANNALS OF NEUROLOGY, 1990, 27 (04) : 373 - 385
  • [7] A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity
    Heinz, A
    Jones, DW
    Mazzanti, C
    Goldman, D
    Ragan, P
    Hommer, D
    Linnoila, M
    Weinberger, DR
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 47 (07) : 643 - 649
  • [8] A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder
    Kirov, G
    Norton, N
    Jones, I
    McCandless, F
    Craddock, N
    Owen, MJ
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 1999, 2 (04) : 293 - 298
  • [9] Krüger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO
  • [10] 2-X